Loading clinical trials...

Zirconia Reinforced Glass Ionomer in MIH | Clinical Trials | Clareo Health

COMPLETEDNA

Zirconia Reinforced Glass Ionomer in MIH

Effectiveness Of Zirconia Reinforced Glass Ionomer Used In Alternative Restorative Treatment In Molar Incisor Hypomineralization (A Randomized Controlled Clinical Trial And Finite Element Analysis)

NCT05494749•Hams Hamed Abdelrahman

View on ClinicalTrials.gov

Summary

Molar-incisor hypomineralization (MIH) is a qualitative enamel defect, in which molars and incisors involved are prone to post-eruptive enamel breakdown leading to sensitivity, and caries. Atraumatic/Alternative Restorative Treatment (ART) is a minimally invasive procedure. It can be very beneficial in managing MIH-affected molars in communities with limited access to dental care. Zirconia-reinforced GI was recently introduced. It is claimed to serve as a long-term temporary restoration until a more permanent restoration is placed

Eligibility

Age

7 - 10 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Children free from any systemic disease (ASA I).
•Cooperative children showing positive or definitely positive behavior according to Frankl rating scale
•Hypomineralized first permanent molars that are restorable according to MIH Treatment Need Index (MIH-TNI): Index (2a), (2b), (4a), (4b)
•Teeth with dentinal lesions corresponding to ICDAS II score 5 or 6
•No clinical or radiographic evidence of pulpal involvement.

Exclusion Criteria

•Index (0), (1), (2c), (3), (4c) on the MIH Treatment Need Index.
•Patients whose parents will not give their consent to participate in the study
•Non-restorable first permanent molars indicated for extraction

Locations (1)

Alexandria Faculty of Dentistry

Alexandria, Egypt

Key Dates

Start Date

September 1, 2022

Primary Completion Date

December 30, 2023

Completion Date

December 30, 2023

Last Updated

March 19, 2024

Enrollment

ACTUAL participants

Conditions

Molar Incisor Hypomineralization

Interventions

zirconomer

OTHER

HVGI-Equia Forte

OTHER

EVALUATION of PREVENTIVE EFFECT of SEALANTS and LASER THERAPY on DENTAL CARIES and POSTERUPTIVE BREAKDOWN on MOLARS AFFECTED with MOLAR INCISOR HYPOMINERALISATION (RANDOMIZED CLINICAL TRIAL)

NCT06801561

Molar Incisor Hypomineralization

View study

COMPLETED

Molar Incisor Hypomineralization and Hypomineralized Second Primary Molars

NCT05809791

Molar Incisor Hypomineralization

View study

COMPLETEDPHASE4

Interventions to Control Hypersensitivity Pain in Teeth With Insisive Molar Hypomineralization

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 19, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Zirconia Reinforced Glass Ionomer in MIH

Inclusion Criteria

Exclusion Criteria

EVALUATION of PREVENTIVE EFFECT of SEALANTS and LASER THERAPY on DENTAL CARIES and POSTERUPTIVE BREAKDOWN on MOLARS AFFECTED with MOLAR INCISOR HYPOMINERALISATION (RANDOMIZED CLINICAL TRIAL)

Molar Incisor Hypomineralization and Hypomineralized Second Primary Molars

Interventions to Control Hypersensitivity Pain in Teeth With Insisive Molar Hypomineralization

The Desensitising Effect of Nanosilver Fluoride in Molar-Incisor Hypomineralisation

Prevalence of Hypomineralized Second Primary Molars and Its Association with Molar-Incisor Hypomineralization.

Evaluation of Three Different Minimally Invasive Techniques for Management of Enamel Opacities in Patients With Molar Incisor Hypomineralization "Randomized Controlled Clinical Trial"